CN100374141C - Wound-treating powder - Google Patents

Wound-treating powder Download PDF

Info

Publication number
CN100374141C
CN100374141C CNB2006100421665A CN200610042166A CN100374141C CN 100374141 C CN100374141 C CN 100374141C CN B2006100421665 A CNB2006100421665 A CN B2006100421665A CN 200610042166 A CN200610042166 A CN 200610042166A CN 100374141 C CN100374141 C CN 100374141C
Authority
CN
China
Prior art keywords
wound
powder
fine powder
treating
treating powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100421665A
Other languages
Chinese (zh)
Other versions
CN1840090A (en
Inventor
王庆华
张灿菊
李天振
和伟
张萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100421665A priority Critical patent/CN100374141C/en
Publication of CN1840090A publication Critical patent/CN1840090A/en
Application granted granted Critical
Publication of CN100374141C publication Critical patent/CN100374141C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses wound-treating powder which comprises 15 to 30% of rhubarb, 35 to 40% of mirabilite, 5 to 10% of common bletilla pseudobulb, 10 to 17% of purslane herb and 5 to 20% of dandelion according to a proportion by weight. While in production, firstly, the rhubarb, the common bletilla pseudobulb, the purslane herb and the dandelion are mixed and ground into fine powder; then, the mirabilite is ground into fine powder; the two parts of the fine powder are uniformly mixed and sieved by a 325-mesh sieve; sieved materials are packaged in sterilized cloth bags. Compared with the method of only changing medicine on wounds, the use of the wound-treating powder of the present invention has obvious effects on the promotion of wound healing, the effective rate is 100%, and the treatment time is obviously shortened; the wound-treating powder has the advantages of convenient operation, safety, economy and no side effect.

Description

Wound-treating powder
Technical field
The invention belongs to field of medicaments, relate in particular to Wound-treating powder.
Background technology
The wound healing obstacle is incision infection and to split be postoperative common disease and complication especially, in case take place to give patient and family members in spirit, body, work, family and even cause the different infringement of degree economically, serious even life-threatening; Simultaneously also increased pressure, reduced Turnover of beds, even caused medical tangle to the doctor.Conventional treatments was medicine partial closure or infrared ray local irradiations such as the edge of a knife is changed dressings, penicillin in the past, but said method has many drawbacks, and effect is undesirable, medicine partial closure, and patient's pain more very is difficult for accepting; Infrared ray radiation need expose wound, must increase infection chance, and uses inconvenient, uneconomical.For this reason, the inventor through the clinical research more than 1 year, has invented a kind of Wound-treating powder in line with the thought of the combination of Chinese and Western medicine.
Summary of the invention
The objective of the invention is to overcome the deficiency of conventional method treatment wound, a kind of good effect, economy easy to use, safe, Wound-treating powder without any side effects are provided.
Technical scheme of the present invention is: it comprises the Radix Et Rhizoma Rhei of (weight ratio) 15-30%, the Natrii Sulfas of 35-40%, the Pseudobulbus Bletillae (Rhizoma Bletillae) of 5-10%, the Herba Portulacae of 10-17%, the Herba Taraxaci of 5-20%.
During making, earlier that Radix Et Rhizoma Rhei, Pseudobulbus Bletillae (Rhizoma Bletillae), Dens Equi is wide, Herba Taraxaci mixes wears into fine powder, again Natrii Sulfas is worn into fine powder, and with above-mentioned fine powder uniform mixing, with 325 mesh sieves sieve powder, extracting screen underflow, interior the getting final product of cloth bag of sterilization is gone in packing.
During use, on the wound after sterile gauze 4-6 layer covered routine and change dressings, the sack that will more dissipate again covers thereon, fixes with bellyband, and change once every day, and two bags by turns, and 6 days is a course of treatment.
With above-mentioned various medical materials the mechanism of action of wound is illustrated advantage of the present invention below: Chinese medicine thinks that red and swollen, scleroma is due to QI-blood circulation is obstructed, and controls with promoting QI to circulate and dispersing the agglomeration of the pathogens, blood circulation promoting and blood stasis dispelling.The present invention just from then on viewpoint set out, carry out prescription in conjunction with modern pharmacological research.Radix Et Rhizoma Rhei is the Polygonaceae herbaceos perennial in the side, gets its rhizome and is used as medicine, and mainly contains aloe-emodin, emodin and rheotannic acid, the nature and flavor hardship, and cold, effect heat and toxic materials clearing away, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling have hemostasis not stay stasis of blood characteristics; According to modern pharmacological research, Radix Et Rhizoma Rhei has broad-spectrum antibacterial action, but enhancing human body immunity power also has inhibitory action to staphylococcus, dysentery bacterium, Bacillus typhi, streptococcus, bacillus pyocyaneus and fungus etc.Natrii Sulfas is the crystalline solid of natural minerals, mainly contains sodium sulfate, and nature and flavor hardship, salty, cold, effect are rushed down softening the hard mass, heat clearing away down; Sodium sulfate easily forms hyperosmotic solution, helps the absorption of sepage.Pseudobulbus Bletillae (Rhizoma Bletillae) is the orchid family herbaceos perennial, and nature and flavor are sweet, cool, effect astringing to arrest bleeding, detumescence and promoting granulation.Herba Portulacae is annual meat herbaceous plant, nature and flavor acid, cold, effect heat-clearing and toxic substances removing, the blood detumescence of loosing, according to modern pharmacological research, its antibacterial action is strong, and dysentery bacterium, Bacillus typhi, escherichia coli and staphylococcus aureus are all had inhibitory action, clinical in being used to prevent and treat the bacillary dysentery, also can be used for suppurative dermatosis and surgical infection, in addition, Herba Portulacae topical treatment soft tissue injury is respond well.Herba Taraxaci is a herbaceos perennial, nature and flavor hardship, sweet, cold, and effect heat-clearing and toxic substances removing, diuresis eliminating stagnation, it has good anti-infectious function.With above-mentioned all medicine compatibilities, detoxicating and resolving stagnation of pathogens, clots absorbing detumescence spread on wound outward and play softening scleroma, blood circulation promoting, accelerating wound.Empirical tests promotes that with of the present invention more the dissipation the simple wound of the wound healing effect of changing dressings is remarkable, effective percentage 100%, and treatment time obviously shortens, and easy to use, and safety economy is without any side effects.
In clinical research, after the discovery patient had used more dissipation of the present invention, the incidence rate of constipation was extremely low, and the patient of postoperative intestine flatulence also obviously reduces.
The specific embodiment
Get 45g Radix Et Rhizoma Rhei, 17g Pseudobulbus Bletillae (Rhizoma Bletillae), 33g Herba Portulacae, 35g Herba Taraxaci and mix and wear into fine powder, other gets 70g mirabilite powder comminution and becomes fine powder, and with above fine powder uniform mixing, with 400 mesh sieves sieve powder, extracting screen underflow, the sterilization cloth bag of the 18*18cm that packs into is interior to get final product.
With several specific embodiments clinical result of use of the present invention is described below:
Embodiment one, Xintai City Traditional Chinese Medicine Hospital's department of obstetrics and gynecology are selected abdominal postoperative edge of a knife redness, scleroma, sepage and fatty plump person 180 examples, wherein edge of a knife external application is healed dissipation person's 100 examples as experimental group, edge of a knife person's 80 examples of not changing dressings are merely organized in contrast, and the result shows that the test group treatment rate is apparently higher than matched group, treatment time, the former obviously shortened, total effective rate experimental group 100%, 77.5%, two group relatively there were significant differences for matched group.
Embodiment two, the Xintai City the People's Hospital, begin 60 routine belly edge of knife patients on one's body with more dissipation treatment of the present invention in January, 2005, clinical experiment through 10 months 60 routine patients, find that the present invention has unique curative effect to the control wound healing is bad, and use convenient, safety economy, the patient is easy to accept, be better than additive method, be subjected to medical worker and patient's favorable comment deeply.
Embodiment three, Xintai City second the People's Hospital, begin to use medicine of the present invention in February, 2005, through the clinical use of 90 routine patients, find that this more dissipates external application on belly edge of knife, therapeutic effect is obvious, promote that wound healing has certain effect, avoided the generation of post-operative complication to a great extent, and application is convenient, economical, without any side effects.

Claims (1)

1. Wound-treating powder, it forms following various components through pulverizing, fine grinding, mixing, screening, pack, it is characterized in that each component and weight ratio thereof are: Radix Et Rhizoma Rhei 15-30%, Natrii Sulfas 35-40%, Pseudobulbus Bletillae (Rhizoma Bletillae) 5-10%, Herba Portulacae 10-17%, Herba Taraxaci 5-20%.
CNB2006100421665A 2006-01-06 2006-01-06 Wound-treating powder Expired - Fee Related CN100374141C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100421665A CN100374141C (en) 2006-01-06 2006-01-06 Wound-treating powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100421665A CN100374141C (en) 2006-01-06 2006-01-06 Wound-treating powder

Publications (2)

Publication Number Publication Date
CN1840090A CN1840090A (en) 2006-10-04
CN100374141C true CN100374141C (en) 2008-03-12

Family

ID=37029393

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100421665A Expired - Fee Related CN100374141C (en) 2006-01-06 2006-01-06 Wound-treating powder

Country Status (1)

Country Link
CN (1) CN100374141C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105106675A (en) * 2013-12-31 2015-12-02 刘凤玲 Preparation method of thick paste for wounds after healing
CN105311391A (en) * 2015-01-26 2016-02-10 杨家驥 Chinese herbal medicine for treating open wound and preparation method thereof
CN105250711A (en) * 2015-11-16 2016-01-20 青岛麦瑞特医药技术有限公司 Traditional Chinese medicine composition for treating abdominal incision induration after cesarean delivery operation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1190590A (en) * 1998-01-13 1998-08-19 覃道华 Medicine for removing carbuncle and eliminating sore

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1190590A (en) * 1998-01-13 1998-08-19 覃道华 Medicine for removing carbuncle and eliminating sore

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中药熏洗治疗痔瘘. 赵燕.中国民间疗法,第10卷第1期. 2002 *
古国明等. 箍围药应用举隅.中医外治杂志,第14卷第4期. 2005 *
痔瘘洗剂1号抑菌抗炎和镇痛作用的实验研究. 陈凤兰.河南中医药学刊,第10卷第6期. 1995 *
硝黄五倍汤外洗治疗痔疮. 陈治国.中国肛肠病杂志,第8卷第1期. 1988 *

Also Published As

Publication number Publication date
CN1840090A (en) 2006-10-04

Similar Documents

Publication Publication Date Title
CN102178634B (en) Pearl essence skin-whitening prickly heat powder
CN102028793A (en) Traditional Chinese medicinal composition for treating burns and scalding
CN101569696A (en) Chinese medicament for traumatic wound
CN102283969A (en) Ointment for pressure sores
CN111297961A (en) Dong medicine for promoting wound healing
CN100374141C (en) Wound-treating powder
CN101850092A (en) Medicament for treating trauma and preparation method thereof
CN101214321A (en) Acne-treating medicine
CN1189197C (en) Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration
CN103417614A (en) Traditional Chinese medicine for treating hemorrhoid
CN104107376A (en) Composition and preparation method of external anti-inflammatory drug
CN107050242A (en) Treat Chinese medicine composition, the preparation method and applications of acute soft tissue injury
CN105832973A (en) External medicine applied to nursing after appendectomy and preparation method
CN1211102C (en) Chinese medicine capsule for curing facial acne
CN106491568A (en) A kind of marine organisms spray film for treating skin injury and infection and preparation method thereof
CN1520851A (en) Ulcerative stomatitis powder
CN101934031B (en) Bone-strengthening and granulation-promoting paste for treating chronic pyogenic osteomyelitis and aseptic necrosis of femoral head and preparation method thereof
CN101843846A (en) Chinese medicinal ointment for treating skin diseases
CN101297937B (en) Chinese patent medicine formulation for treating cervical vertebra disease and preparation thereof
CN102940661A (en) Medicine for treating parotitis
CN1209161C (en) Medicine for external application for curing cervical erosion
CN100562330C (en) A kind of Chinese powder medicine of analgetic, hemostatic repercussive and sore-arresting functions and compound method thereof
CN1095926A (en) A kind of multi-effect powder for the treatment of diseases such as carbuncle and treatment skin ulcer and preparation method thereof
CN1201779C (en) Medicine for curing reduction of fracture and its production method
CN104857262A (en) Pure Chinese material medicine preparation for treating knife wounds and postoperative pyogenic infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080312

Termination date: 20100207